2017 Drug Development Insurance Coverage and Processing 
Pharmaceutical Technology
NOVEMBER 30, 2022
A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. In addition to these issues, further barriers to drug access remain in the UK and US.
Pharmaceutical Technology
NOVEMBER 30, 2022
A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. In addition to these issues, further barriers to drug access remain in the UK and US.
Putting Patients First Blog
MAY 29, 2024
1 This trend underscores the importance of informed decision-making for those with chronic diseases and disabilities, who face crucial choices regarding their health care coverage – whether selecting between traditional Medicare and MA, choosing among MA plans, or navigating their selected plan to access necessary care. As of 2023, 30.8
Expert insights. Personalized for you.
Let's personalize your content